Jeremiah Havins
Interventional Cardiology · Hewitt, TXNPI 1427217009
Payments from drug & device makers
Across 372 payments — averaging $28.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Biotronik Inc.$1K
- Organogenesis Inc.$800
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$605
- Johnson & Johnson$502
- Novartis$391
- plus $4K from 34 others
What the payments were for
- Speaking & faculty fees$8008%
- Food & beverage$9,55092%
- Education$721%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 78 | $2,307 |
| Biotronik Inc. | 22 | $1,419 |
| Organogenesis Inc. | 1 | $800 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 38 | $605 |
| Johnson & Johnson | 26 | $502 |
| Novartis | 28 | $391 |
| Impulse Dynamics (USA) Inc. | 4 | $386 |
| Pfizer | 24 | $375 |
| Abbott | 5 | $358 |
| AstraZeneca | 19 | $311 |
| Abiomed | 5 | $308 |
| Amarin Pharma, Inc. | 17 | $282 |
| Acist Medical Systems, Inc. | 3 | $253 |
| Boehringer Ingelheim | 15 | $239 |
| E.r. Squibb & Sons, L.L.C. | 15 | $212 |
| Boston Scientific | 4 | $181 |
| Inari Medical, Inc. | 1 | $173 |
| Novo Nordisk | 8 | $151 |
| Merz North America, Inc. | 3 | $147 |
| Tactile Systems Technology Inc | 11 | $145 |
| Vifor Pharma, Inc. | 7 | $143 |
| Angiodynamics, Inc. | 4 | $98 |
| Kowa Pharmaceuticals America, Inc. | 6 | $85 |
| Merck | 5 | $81 |
| Esperion Therapeutics, Inc. | 3 | $55 |
| Amgen | 3 | $53 |
| Itamar Medical Inc | 1 | $52 |
| Braemar Manufacturing, LLC | 1 | $43 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Philips North America LLC | 1 | $26 |
| Arbor Pharmaceuticals, Inc. | 2 | $24 |
| Cardiovascular Systems Inc. | 2 | $24 |
| Galderma Laboratories, L.p. | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Bayer | 1 | $21 |
| Avinger Inc. | 1 | $20 |
| Celonova Biosciences, Inc. | 1 | $14 |
| AbbVie | 1 | $13 |
| Bardy Diagnostics, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$800
- BioMonitor$564
- Edora$443
- Acticor$443
- Solia$443
- Rivacor$443
- Resolute$277
- Impella$240
- COREVALVE EVOLUT R$237
- FLOWTRIEVER CATHETER, S$173
- CT THROMBECTOMY SYSTEM KIT$173
- ASSURITY$163
- CardioMEMS HF System$138
- OPTIMIZER$127
- ClosureFast$122
- RXI SYSTEMS$120
- HD-IVUS$114
- Varithena Administration Pack$113
- CoreValve Evolut$108
- OPTIMIZER SMART SYSTEM$106
How this compares
$10,422 in reported general payments places this provider in the 50th percentile of 686 interventional cardiology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 14 | $142 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Hewitt
- Robert StolerDallas$8.2M
- James ChoiDallas$5.2M
- Srinivasa PotluriPlano$5.1M
- Neal KleimanHouston$4.8M
- Juan GranadaHouston$4.3M
- Ira LieberKingwood$3.3M
- Cara Ann EastDallas$3M
- Abhijeet DhobleHouston$2.7M
- Jeffrey CarrTyler$2.7M
- M Asad KarimMcKinney$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.